The six-month clinical study will enroll 100 adults starting weight-loss drug therapy to test whether smartwatch data can ...

Samsung has launched a clinical study to explore how smartwatch data can mitigate muscle mass loss in adults receiving GLP-1 therapy.

Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, ...

A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes while highlighting drug-specific advantages and the need to manage ...

Genetic analysis revealed a response the team calls “reboot and rebound,” a pattern of gene shutdown followed by reactivation ...